| DAA900 |
Urine concentrating capacity decreases |
Physiological |
renal tubule |
Human |
— |
— |
|
| DAA966 |
Vaccination antibody response is impaired |
Physiological |
immune system |
Human |
— |
— |
|
| DAA384 |
vacuolar protein sorting 13 homolog C (S. cerevisiae) |
Molecular |
skeletal muscle |
Human |
VPS13C |
3.0% Increase Gene Expression Level |
|
| DAA2104 |
vacuolar protein sorting 13 homolog C (S. cerevisiae) decreases with age |
Molecular |
ovary |
Human |
VPS13C |
58.7% Decrease Gene Expression Level |
|
| DAA1061 |
Variability in clearance of hepatically metabolized drugs |
Physiological |
liver |
Human |
— |
— |
|
| DAA778 |
Variability of performance for multiple cognitive tasks increases |
Psychological |
brain |
Human |
— |
— |
|
| DAA2043 |
Variations in body weight |
Physiological |
whole body |
Human |
— |
— |
|
| DAA2044 |
Variations in fat mass |
Physiological |
adipose tissue |
Human |
— |
— |
|
| DAA423 |
vascular endothelial growth factor B |
Molecular |
skeletal muscle |
Human |
VEGFB |
6.0% Decrease Gene Expression Level |
|
| DAA896 |
Vasodilation induced by acetylcholine or sodium reduced |
Physiological |
renal vasculature |
Human |
— |
— |
|
| DAA794 |
Ventilatory rate at maximum exertion decreases |
Physiological |
lung |
Human |
— |
— |
|
| DAA776 |
Verbal memory declines |
Psychological |
brain |
Human |
— |
— |
|
| DAA50 |
versican |
Molecular |
brain |
Human |
VCAN |
20.0% Increase Gene Expression Level |
|
| DAA517 |
very low density lipoprotein receptor |
Molecular |
skeletal muscle |
Human |
VLDLR |
4.0% Decrease Gene Expression Level |
|
| DAA245 |
vesicle-associated membrane protein 2 (synaptobrevin 2) |
Molecular |
brain |
Human |
VAMP2 |
4.0% Decrease Gene Expression Level |
|
| DAA246 |
vesicle-associated membrane protein 3 (cellubrevin) |
Molecular |
brain |
Human |
VAMP3 |
7.0% Increase Gene Expression Level |
|
| DAA565 |
vesicle transport through interaction with t-SNAREs homolog 1B (yeast) |
Molecular |
skeletal muscle |
Human |
VTI1B |
3.0% Decrease Gene Expression Level |
|
| DAA248 |
vimentin |
Molecular |
brain |
Human |
VIM |
11.0% Increase Gene Expression Level |
|
| DAA588 |
Viral hepatitis |
Pathological |
liver |
Human |
— |
SeriesMorbidity |
|
| DAA788 |
Viscoelastic modulus of brain tissue decreases |
Physiological |
brain |
Human |
— |
— |
|
| DAA249 |
visinin-like 1 |
Molecular |
brain |
Human |
VSNL1 |
6.0% Decrease Gene Expression Level |
|
| DAA2583 |
Vision loss |
Physiological |
visual apparatus |
Human |
— |
— |
|
| DAA777 |
Visual memory declines |
Psychological |
brain |
Human |
— |
— |
|
| DAA247 |
voltage-dependent anion channel 1 |
Molecular |
brain |
Human |
VDAC1 |
10.0% Decrease Gene Expression Level |
|
| DAA936 |
Volume of hematopoietic bone marrow decreases |
Physiological |
bone marrow |
Human |
— |
— |
|